Zentalis Pharmaceuticals Statistics
Total Valuation
ZNTL has a market cap or net worth of $107.12 million. The enterprise value is -$154.99 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ZNTL has 72.14 million shares outstanding. The number of shares has increased by 0.90% in one year.
| Current Share Class | 72.14M |
| Shares Outstanding | 72.14M |
| Shares Change (YoY) | +0.90% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 1.59% |
| Owned by Institutions (%) | 54.55% |
| Float | 49.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.95 |
| Forward PS | n/a |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.99, with a Debt / Equity ratio of 0.15.
| Current Ratio | 7.99 |
| Quick Ratio | 7.78 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.55% and return on invested capital (ROIC) is -28.86%.
| Return on Equity (ROE) | -49.55% |
| Return on Assets (ROA) | -25.41% |
| Return on Invested Capital (ROIC) | -28.86% |
| Return on Capital Employed (ROCE) | -54.83% |
| Revenue Per Employee | $161,837 |
| Profits Per Employee | -$980,620 |
| Employee Count | 166 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -232,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.71% in the last 52 weeks. The beta is 1.77, so ZNTL's price volatility has been higher than the market average.
| Beta (5Y) | 1.77 |
| 52-Week Price Change | -47.71% |
| 50-Day Moving Average | 1.62 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 42.64 |
| Average Volume (20 Days) | 773,403 |
Short Selling Information
The latest short interest is 4.94 million, so 6.84% of the outstanding shares have been sold short.
| Short Interest | 4.94M |
| Short Previous Month | 4.42M |
| Short % of Shares Out | 6.84% |
| Short % of Float | 9.88% |
| Short Ratio (days to cover) | 6.68 |
Income Statement
In the last 12 months, ZNTL had revenue of $26.87 million and -$162.78 million in losses. Loss per share was -$2.28.
| Revenue | 26.87M |
| Gross Profit | 26.87M |
| Operating Income | -171.43M |
| Pretax Income | -163.02M |
| Net Income | -162.78M |
| EBITDA | -170.37M |
| EBIT | -171.43M |
| Loss Per Share | -$2.28 |
Full Income StatementBalance Sheet
The company has $303.43 million in cash and $41.32 million in debt, giving a net cash position of $262.11 million or $3.63 per share.
| Cash & Cash Equivalents | 303.43M |
| Total Debt | 41.32M |
| Net Cash | 262.11M |
| Net Cash Per Share | $3.63 |
| Equity (Book Value) | 274.50M |
| Book Value Per Share | 3.81 |
| Working Capital | 272.57M |
Full Balance SheetCash Flow
| Operating Cash Flow | -151.09M |
| Capital Expenditures | n/a |
| Free Cash Flow | -151.09M |
| FCF Per Share | -$2.09 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -638.12% |
| Pretax Margin | -606.79% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ZNTL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.90% |
| Shareholder Yield | -0.90% |
| Earnings Yield | -151.96% |
| FCF Yield | -141.05% |
Dividend DetailsAnalyst Forecast
The average price target for ZNTL is $6.53, which is 339.73% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.53 |
| Price Target Difference | 339.73% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 19.74% |
| EPS Growth Forecast (5Y) | -40.54% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ZNTL has an Altman Z-Score of -3.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.65 |
| Piotroski F-Score | 2 |
